Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metabolism and pharmacokinetics of naloxone.

× No keyword cloud information.

10 in total

1. Ineffective ventilation during conscious sedation due to chest wall rigidity after intravenous midazolam and fentanyl.

Authors: W E Ackerman; J C Phero; G T Theodore
Journal: Anesth Prog Date: 1990 Jan-Feb

Review 2. Role of active metabolites in the use of opioids.

Authors: Janet K Coller; Lona L Christrup; Andrew A Somogyi
Journal: Eur J Clin Pharmacol Date: 2008-10-29 Impact factor: 2.953

3. Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.

Authors: Pallabi Mitra; Jürgen Venitz; Yunyun Yuan; Yan Zhang; Phillip M Gerk
Journal: Drug Metab Dispos Date: 2011-06-17 Impact factor: 3.922

4. Pharmacokinetics of Sublingual Buprenorphine and Naloxone in Subjects with Mild to Severe Hepatic Impairment (Child-Pugh Classes A, B, and C), in Hepatitis C Virus-Seropositive Subjects, and in Healthy Volunteers.

Authors: Azmi F Nasser; Christian Heidbreder; Yongzhen Liu; Paul J Fudala
Journal: Clin Pharmacokinet Date: 2015-08 Impact factor: 6.447

Review 5. Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors: D E Drayer
Journal: Clin Pharmacokinet Date: 1976 Nov-Dec Impact factor: 6.447

6. Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers.

Authors: Ashraf Yassen; Erik Olofsen; Eveline van Dorp; Elise Sarton; Luc Teppema; Meindert Danhof; Albert Dahan
Journal: Clin Pharmacokinet Date: 2007 Impact factor: 6.447

7. Naloxone has no effect on ethanol-induced impairment of psychomotor performance in man.

Authors: K D Bird; G B Chesher; J Perl; G A Starmer
Journal: Psychopharmacology (Berl) Date: 1982 Impact factor: 4.530

8. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain.

Authors: Sam H Ahmedzai; Friedemann Nauck; Gil Bar-Sela; Björn Bosse; Petra Leyendecker; Michael Hopp
Journal: Palliat Med Date: 2011-09-21 Impact factor: 4.762

9. Absorption, distribution, metabolism, and excretion of [14C]-labeled naloxegol in healthy subjects.

Authors: Khanh Bui; Fahua She; Michael Hutchison; Åsa Brunnström; Mark Sostek
Journal: Int J Clin Pharmacol Ther Date: 2015-10 Impact factor: 1.366

10. The Effects of Intramuscular Naloxone Dose on Mu Receptor Displacement of Carfentanil in Rhesus Monkeys.

Authors: Peter J H Scott; Robert A Koeppe; Xia Shao; Melissa E Rodnick; Alexandra R Sowa; Bradford D Henderson; Jenelle Stauff; Phillip S Sherman; Janna Arteaga; Dennis J Carlo; Ronald B Moss
Journal: Molecules Date: 2020-03-17 Impact factor: 4.411

10 in total